Louisville Metabolic and Atherosclerosis Research Center — Louisville, Kentucky

Louisville Metabolic and Atherosclerosis Research Center is a clinical research site located in Louisville, Kentucky, United States 40213.

Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.

Louisville Metabolic and Atherosclerosis Research Center has participated in 25 clinical trials with 5 currently active.

Therapeutic areas: Hypertriglyceridemia, Lipidemia, Type 2 Diabetes (T2DM).

Sponsors: Arisaph Pharmaceuticals Inc, NewAmsterdam Pharma, Amgen.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Louisville

Browse all research sites in Kentucky · View every site in Louisville

Sponsor Feasibility Report

Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Louisville Metabolic and Atherosclerosis Research Center?

Louisville Metabolic and Atherosclerosis Research Center has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Louisville Metabolic and Atherosclerosis Research Center conducted?

Louisville Metabolic and Atherosclerosis Research Center has 25 clinical trials on record, with 5 currently active. Their work covers Hypertriglyceridemia, Lipidemia, Type 2 Diabetes (T2DM).

Is Louisville Metabolic and Atherosclerosis Research Center accredited by Crixeo Clinical Trials?

Louisville Metabolic and Atherosclerosis Research Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Louisville Metabolic and Atherosclerosis Research Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.